ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 72 filers reported holding ANI PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $272,000 | -20.9% | 4,415 | -27.4% | 0.00% | 0.0% |
| Q3 2018 | $344,000 | +4.6% | 6,082 | +23.5% | 0.00% | 0.0% |
| Q2 2018 | $329,000 | -87.1% | 4,925 | -88.8% | 0.00% | -66.7% |
| Q1 2018 | $2,555,000 | -9.3% | 43,890 | +0.5% | 0.01% | -14.3% |
| Q4 2017 | $2,817,000 | +2.5% | 43,691 | -16.6% | 0.01% | +16.7% |
| Q3 2017 | $2,748,000 | +12.2% | 52,366 | -0.0% | 0.01% | 0.0% |
| Q2 2017 | $2,450,000 | -10.5% | 52,389 | -5.2% | 0.01% | -14.3% |
| Q1 2017 | $2,737,000 | -12.2% | 55,288 | +7.5% | 0.01% | -22.2% |
| Q4 2016 | $3,117,000 | +141.1% | 51,415 | +163.9% | 0.01% | +125.0% |
| Q3 2016 | $1,293,000 | +7.3% | 19,480 | -9.8% | 0.00% | 0.0% |
| Q2 2016 | $1,205,000 | +1.9% | 21,594 | -17.6% | 0.00% | +33.3% |
| Q4 2015 | $1,183,000 | -47.3% | 26,198 | -59.8% | 0.00% | -50.0% |
| Q2 2014 | $2,246,000 | – | 65,222 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 327,929 | $9,218,000 | 3.24% |
| Parkman Healthcare Partners LLC | 107,911 | $3,033,000 | 0.89% |
| Global Alpha Capital Management Ltd. | 350,231 | $9,845,000 | 0.85% |
| MARATHON CAPITAL MANAGEMENT | 75,010 | $2,109,000 | 0.60% |
| TANG CAPITAL MANAGEMENT LLC | 100,000 | $2,811,000 | 0.56% |
| EMERALD ADVISERS, LLC | 354,045 | $9,952,000 | 0.38% |
| Sio Capital Management, LLC | 40,000 | $1,124,000 | 0.37% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 299,493 | $8,419,000 | 0.37% |
| Stonepine Capital Management, LLC | 26,060 | $733,000 | 0.30% |
| Mitsubishi UFJ Asset Management (UK) Ltd. | 23,000 | $646,530,000 | 0.29% |